1. Home
  2. STXS vs JHI Comparison

STXS vs JHI Comparison

Compare STXS & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • JHI
  • Stock Information
  • Founded
  • STXS 1990
  • JHI 1971
  • Country
  • STXS United States
  • JHI United States
  • Employees
  • STXS N/A
  • JHI N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • JHI Trusts Except Educational Religious and Charitable
  • Sector
  • STXS Health Care
  • JHI Finance
  • Exchange
  • STXS Nasdaq
  • JHI Nasdaq
  • Market Cap
  • STXS 151.3M
  • JHI N/A
  • IPO Year
  • STXS 2004
  • JHI N/A
  • Fundamental
  • Price
  • STXS $2.18
  • JHI $13.30
  • Analyst Decision
  • STXS
  • JHI
  • Analyst Count
  • STXS 0
  • JHI 0
  • Target Price
  • STXS N/A
  • JHI N/A
  • AVG Volume (30 Days)
  • STXS 285.8K
  • JHI 29.5K
  • Earning Date
  • STXS 05-12-2025
  • JHI 01-01-0001
  • Dividend Yield
  • STXS N/A
  • JHI 6.80%
  • EPS Growth
  • STXS N/A
  • JHI N/A
  • EPS
  • STXS N/A
  • JHI 1.05
  • Revenue
  • STXS $26,918,000.00
  • JHI N/A
  • Revenue This Year
  • STXS $25.90
  • JHI N/A
  • Revenue Next Year
  • STXS $60.57
  • JHI N/A
  • P/E Ratio
  • STXS N/A
  • JHI $12.47
  • Revenue Growth
  • STXS 0.55
  • JHI N/A
  • 52 Week Low
  • STXS $1.54
  • JHI $11.63
  • 52 Week High
  • STXS $2.72
  • JHI $13.40
  • Technical
  • Relative Strength Index (RSI)
  • STXS 66.61
  • JHI 57.17
  • Support Level
  • STXS $1.93
  • JHI $13.16
  • Resistance Level
  • STXS $2.07
  • JHI $13.30
  • Average True Range (ATR)
  • STXS 0.09
  • JHI 0.10
  • MACD
  • STXS 0.03
  • JHI 0.06
  • Stochastic Oscillator
  • STXS 94.05
  • JHI 93.65

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: